Federal contract award
75F40124P00492
THE OBJECTIVE OF THIS CONTRACT IS TO ACQUIRE SUBJECT MATTER EXPERT FOR "EVALUATING THE EFFECT OF OBESITY ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF MONOCLONAL ANTIBODIES IN PEDIATRIC PATIENTS".
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AJ11 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $70.1K |
| Current contract value | $70.1K |
| Potential contract value / ceiling | $70.1K |
| Start date | Sep 20, 2024 |
| Current end date | Sep 29, 2026 |
| Potential end date | Sep 29, 2026 |
| Latest award activity | Aug 5, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 5, 2026 | P00001 | $-15.9K | THE OBJECTIVE OF THIS CONTRACT IS TO ACQUIRE SUBJECT MATTER EXPERT FOR "EVALUATING THE EFFECT OF OBESITY ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF MONOCLONAL ANTIBODIES IN PEDIATRIC PATIENTS". -FY26 UDO INIATIVE |
| Sep 20, 2024 | 0 | $86.0K | THE OBJECTIVE OF THIS CONTRACT IS TO ACQUIRE SUBJECT MATTER EXPERT FOR "EVALUATING THE EFFECT OF OBESITY ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF MONOCLONAL ANTIBODIES IN PEDIATRIC PATIENTS". |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.